Pandemic influenza and hospital resources

Emerging Infectious Diseases

Volumn 13, Issue 11, 2007, Pages 1714-1719

  Nap, Raoul E ^a   Andriessen, Maarten P H M ^a   Meessen, Nico E L ^a   Van Der Werf, Tjip S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ARTICLE; CLINICAL DECISION MAKING; COMPUTER MODEL; DISEASE CONTROL; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL BED CAPACITY; HOSPITAL CARE; HOSPITAL MANAGEMENT; INFLUENZA; INTENSIVE CARE UNIT; INTERVIEW; LONG TERM CARE; PANDEMIC; TELEPHONE; WORLD HEALTH ORGANIZATION;

EID: 36248970210     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1311.070103     Document Type: Article

References (31)

1. Bartlett JG. Planning for avian influenza. Ann Intern Med. 2006;145:141-4.
2. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374-85.
3. Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis. 2006;12:73-7.
4. Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet. 2006;367:1405-11.
5. Tsang KW, Eng P, Liam CK, Shim YS, Lam WK. H5N1 influenza pandemic: contingency plans. Lancet. 2005;366:533-4.
6. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004;101:1356-61.
7. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004;363:587-93.
8. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO [cited 2007 May 10]. Available from http://www.who.int/csr/disease/avian_influenza/country/en/index.html
9. Webster RG, Govorkova EA. H5N1 influenza - continuing evolution and spread. N Engl J Med. 2006;355:2174-7.
10. Nicoll A. Human H5N1 infections: so many cases - why so little knowledge? Euro Surveill. 2006;11:11-4.
11. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJD, Chau TNB, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203-7.
12. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442:448-52.
13. Gruber PC, Gomersall CD, Joynt GM. Avian influenza (H5N1): implications for intensive care. Intensive Care Med. 2006;32:823-9.
14. Menon DK, Taylor BL, Ridley SA. Modelling the impact of an influenza pandemic on critical care services in England. Anaesthesia. 2005;60:952-4.
15. Hick JL, O'Laughlin DT. Concept of operations for triage of mechanical ventilation in an epidemic. Acad Emerg Med. 2006;13:223-9.
16. Anderson TA, Hart GK, Kainer MA. Pandemic influenza - implications for critical care resources in Australia and New Zealand. J Crit Care. 2003;18:173-80.
17. Centers for Disease Control and Protection. FluSurge2.0: a manual to assist state and local public health officials and hospital administrators in estimating the impact of an influenza pandemic on hospital surge capacity (beta test version). Atlanta: The Centers; 2005. Available from http://www.cdc.gov/ flu/tools/flusurge
18. Centraal Bureau voor de Statistiek. Statistisch jaarboek 2006. Heerlen (the Netherlands): Centraal Bureau voor de Statistiek; 2006.
19. Hagenaars TJ, Van Genugten MLL, Wallinga J. Scenario analysis of transmission dynamics, health-care demand and mortality. Brief report to the Health Inspectorate of the Netherlands. Bilthoven (the Netherlands): RIVM; 2003.
20. Van Genugten MLL, Heijnen MLA, Jager JC. Scenario ontwikkeling zorgvraag bij een influenzapandemie. RIVM rapport 217617 004. Bilthoven (the Netherlands): RIVM; 2001.
21. Nordstrom BL, Sung I, Suter P, Szneke P. Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Curr Med Res Opin. 2005;21:761-8.
22. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 2006;443:578-81.
23. Bournes DA, Ferguson-Pare M. Persevering through a difficult time during the SARS outbreak in Toronto. Nurs Sci Q. 2005;18:324-33.
24. Straus SE, Wilson K, Rambaldini G, Rath D, Lin Y, Gold WL, et al. Severe acute respiratory syndrome and its impact on professionalism: qualitative study of physicians' behaviour during an emerging healthcare crisis. BMJ. 2004;329:83.
25. Loeb M, McGeer A, Henry B, Ofner M, Rose D, Hlywka T, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis. 2004;10:251-5.
26. Seto WH, Tsang D, Yung RWH, Ching TY, Ng TK, Ho M, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003;361:1519-20.
27. van der Werf TS, Zijlstra JG, Ligtenberg JJ, Tulleken JE. Beslissingen rond het levenseinde op de Intensive Care: overgang van curatieve naar paliatieve behandeling. Ned Tijdschr Geneeskd. 2005;149:742-6.
28. Boussarsar M, Bouchoucha S. Dying at home: cultural and religious preferences. Intensive Care Med. 2006;32:1917-8.
29. Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ. 2006;332:1077-9.
30. Bonten MJM, Prins JM. Antibiotics in pandemic flu. BMJ. 2006;332:248-9.
31. Gill JS, Webby R, Gilchrist MJ, Gray GC. Avian influenza among waterfowl hunters and wildlife professionals. Emerg Infect Dis. 2006;12:1284-6.